HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,201-1,212 of 1,979
Drug study icon
CompletedNCT00314821

Ropinirole in the Treatment of Depression in bipolarity

Official study title

A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Atlanta
Bipolarity, DepressionMedication studyAges 18–64
Countries
United States
Sponsor
Cambridge Health Alliance
Device study icon
WithdrawnNCT00447096

rTMS for Treatment of Depressed Phase of Bipolarity type II

Official study title

rTMS (Repetitive Transcranial Magnetic Stimulation) for Acute Treatment of Depressed Phase of Bipolar Disorder Type II

This study was withdrawn before enrollment.

In Dallas
Bipolarity, DepressionDevice studyAges 18–65
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Drug study icon
WithdrawnNCT00359125

RU-486 in the Treatment of Depression in bipolarity

Official study title

Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.

This study was withdrawn before enrollment.

In Vancouver
Bipolarity, DepressionMedication studyAges 19–65
Countries
Canada
Sponsor
University of British Columbia
Drug study icon
CompletedNCT00852202

Safety and Efficacy of RGH-188 (Cariprazine) in Depression in bipolarity

What is this study about?

Researchers compared cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Encino
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT00060489

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity

Official study title

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
AstraZeneca
Drug study icon
TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

Official study title

A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

This study ended early.

Multiple locations, including Dothan
Bipolarity, SchizophreniaMedication studyAges 10–17
Countries
United States, Bulgaria, Croatia, + 10 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01396447

Safety study of safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression in depression in bipolarity

What is this study about?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States, Canada, Bulgaria, + 3 others
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT04211961

Scopolamine in Depression in bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Scopolamine for people with bipolarity.

This study has finished and is no longer accepting participants.

In Galway
Bipolarity, DepressionMedication studyAges 18+
Countries
Ireland
Sponsor
Dr. Brian Hallahan
Drug study icon
CompletedNCT02974010

Sequential Therapy for Severe Depression in bipolarity.

Official study title

Sequential Therapy (NRX-100 Followed by NRX-101) for the Treatment of Acute Suicidal Ideation and Behavior in Bipolar Depression: the STABIL-B Study

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, Depression, ...Medication studyAges 18–65
Countries
United States
Sponsor
NeuroRx, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.